Comparison of the toxicity profile of PD‐1 versus PD‐L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|124|2|271-277

ISSN： 0008-543x

Source： CANCER, Vol.124, Iss.2, 2018-01, pp. : 271-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management

By  

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 62-68

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 92, Iss. 5, 2017-02 ,pp. : 283-290

Karger

Access to resources Recommend Favorite

Interlaboratory concordance of PD‐L1 immunohistochemistry for non‐small‐cell lung cancer

By  

HISTOPATHOLOGY, Vol. 72, Iss. 3, 2018-02 ,pp. : 449-459

John Wiley & Sons Inc

Access to resources Recommend Favorite

PD-1/PD-L1 Pathway in Breast Cancer

By  

Oncology Research and Treatment, Vol. 40, Iss. 5, 2017-03 ,pp. : 294-297

Karger

Access to resources Recommend Favorite

Non‐small cell lung cancer

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 1, 2015-03 ,pp. : 49-53

John Wiley & Sons Inc

Access to resources Recommend Favorite